Evidence map›Paper›PMID 41159352›Full record

ArticleArchives of Iranian medicine2025

Trends and the Age-Period-Cohort Effects on Mortality of Breast Cancer Among Iranian Women from 1990 to 2021.

Fatemeh Jafari, Soheila Khodakarim, Abbas Rezaianzadeh, Hamed Karami

Abstract read
In one paragraph

Article in Archives of Iranian medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fatemeh JafariStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID 0000-0003-2392-4516
Soheila KhodakarimDepartment of Biostatistics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.ORCID 0000-0002-5473-999X
Abbas RezaianzadehColorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Hamed KaramiStudent Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Eastern Mediterranean Region, including Iran, has the highest incidence and mortality of breast cancer (BC) in women. This study examined changes in BC mortality trends among Iranian women by age period cohort (APC) from 1990 to 2021.

methodsBC deaths and population by age (1990‒2021) were collected from the 2021 Global Burden of Disease (GBD) study and the average annual percentage change (AAPC) and relative risks (RRs) analyzed by joinpoint regression and the APC model.

resultsFrom 1990 to 2021, the crude and adjusted BC mortality rates showed an increasing (AAPC=0.913%; 95% CI: 0.436%, 1.393%) and decreasing (AAPC=-0.384%, 95% CI: -0.759%, -0.008%) trend, respectively. The APC analysis exhibited an increasing trend in age effect except in the 60‒74 and 80‒84 age group. The period effect also presented an increasing trend from 1992 (RR=0.716; 95% CI: 0.697, 0.734) to 2021 (RR=1.410; 95% CI: 1.381, 1.441). Additionally, the cohort effect illustrated that the mortality rate decreased consistently from the earlier birth cohort to the later birth cohort (Coef=1.017 in<1901 cohort versus Coef=-0.928 in 2002-2006 cohort).

conclusionBetween 1990 and 2021, BC mortality in Iran showed an increase in crude rates but a decline in age-adjusted rates, with rising age and period effects and a decreasing cohort effect. These patterns may reflect improvements in early detection and treatment alongside demographic shifts, highlighting the need for continued monitoring to guide control strategies.

Indexed as

Breast NeoplasmsAdultAgedAged, 80 and overAge DistributionAge FactorsCohort EffectCohort StudiesFemaleHumansIncidenceIranMiddle AgedMortalityAge-period-cohort effectBreast cancerJoinpoint regression analysisMortality

Identifiers

PMID41159352
PMCPMC12569991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.